Boston Partners’s Quipt Home Medical QIPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-104,643
Closed -$273K 800
2025
Q3
$273K Sell
104,643
-15,671
-13% -$36.2K ﹤0.01% 725
2025
Q2
$215K Sell
120,314
-100,146
-45% -$198K ﹤0.01% 700
2025
Q1
$514K Buy
220,460
+1,640
+0.7% +$4.5K ﹤0.01% 630
2024
Q4
$667K Sell
218,820
-352,479
-62% -$949K ﹤0.01% 608
2024
Q3
$1.67M Sell
571,299
-337,385
-37% -$1.04M ﹤0.01% 540
2024
Q2
$2.93M Buy
908,684
+166,678
+22% +$598K ﹤0.01% 471
2024
Q1
$3.24M Buy
742,006
+84,182
+13% +$380K ﹤0.01% 465
2023
Q4
$3.35M Sell
657,824
-102,628
-13% -$492K ﹤0.01% 452
2023
Q3
$3.87M Sell
760,452
-14,954
-2% -$80.2K 0.01% 431
2023
Q2
$4.14M Buy
775,406
+40,613
+6% +$240K 0.01% 417
2023
Q1
$5.15M Buy
734,793
+364,607
+98% +$2.25M 0.01% 395
2022
Q4
$1.74M Buy
370,186
+81,802
+28% +$357K ﹤0.01% 459
2022
Q3
$1.2M Buy
288,384
+26,995
+10% +$135K ﹤0.01% 495
2022
Q2
$1.2M Buy
261,389
+133,949
+105% +$617K ﹤0.01% 485
2022
Q1
$559K Buy
127,440
+8,103
+7% +$41K ﹤0.01% 611
2021
Q4
$669K Buy
119,337
+26,338
+28% +$154K ﹤0.01% 582
2021
Q3
$587K Buy
+92,999
New +$558K ﹤0.01% 592

Other funds holding QIPT

Boston Partners's QIPT Position: Q4 2025 in Review

Boston Partners sold out of Quipt Home Medical (QIPT) in Q4 2025, closing a stake of 104,643 shares — an estimated $273K sold.

Boston Partners first reported a position in QIPT in Q3 2021 and held it in 17 quarters. The position peaked at $5.15M in Q1 2023. 70 funds tracked by Wall St. Rank hold QIPT as of Q4 2025.

  • Boston Partners reported no remaining Quipt Home Medical position as of Q4 2025 after selling out during the quarter.
  • Boston Partners sold 104,643 Quipt Home Medical shares in Q4 2025, an estimated $273K.
  • Boston Partners first reported a position in Quipt Home Medical in Q3 2021 and held it in 17 quarters.
  • Boston Partners's Quipt Home Medical position peaked at $5.15M in Q1 2023.
  • 70 funds tracked by Wall St. Rank held Quipt Home Medical as of Q4 2025.

Based on Boston Partners's 13F filing for Q4 2025, filed 13 Feb 2026.